Skip to main content
Back
finqOS
Search a stock, list or screen
⌘K
Not investment advice
Read full disclaimer
IKT
———
Overview
Company
Financials
Valuation
News
Ownership
Documents
IKT: Inhibikase Therapeutics, Inc. Stock Analysis | finqOS
IKT
$1.32
+1.54%
Lists
Call IKT
Inhibikase Therapeutics
IKT
Back
Lists
Call IKT
$1.32
+$0.02 · +1.54%
Closed
Overview
Company
Financials
Valuation
News
Ownership
Documents
Call IKT
Loading chart data...
Signal state